Nota di contenuto |
Practical Diabetes Care; Contents; Preface; Numbers, conversions and tables; 1 Classification and diagnosis; Introduction; Classification; Diagnosis of diabetes in non-pregnant adults; IGT and clinical trials to prevent progression of IGT to diabetes; Screening for diabetes; Prevention of type 1 diabetes; References; Further reading; 2 Diabetes in the emergency department; Introduction; Hyperglycaemic emergencies: diabetic ketoacidosis and hyperglycaemic hyperosmolar state; Management of the clinically well, newly presenting type 1 patient; Precipitating factors; Ketones in DKA
Intensive care unit?Investigations; Management; Follow-up; Hypoglycaemia; The acute diabetic foot; References; Further reading; 3 Management of inpatient diabetes; Introduction; Acute coronary syndromes (ST-segment elevation acute myocardial infarction, non-ST-segment elevation acute myocardial infarction and unstable angina); Atrial fibrillation; Patients in the intensive care unit; Non-critically ill patients; Stroke; Enteral feeding (nasogastric, percutaneous endoscopic gastrostomy); Glucocorticoid treatment; Inpatient screening routine; Perioperative management; References
Further reading4 Type 1 diabetes: insulin treatment; Introduction; Total daily insulin dose requirements; Glycaemic targets in type 1 diabetes; Insulin products; Insulin prescribing; Insulin preparations; Basal-bolus/multiple-dose insulin; Biphasic (fixed-ratio) mixtures; Insulin pump treatment (CSII); Checklist of practical points whenever there is a problem with blood glucose control; Continuous glucose monitoring; New developments; References; Further reading; 5 Type 2 diabetes: general introduction; Introduction: type 2 diabetes as a progressive condition
The general approach to the newly diagnosed type 2 patientLifestyle intervention: diet and exercise; Drug treatment of type 2 diabetes; References; Further reading; 6 Type 2 diabetes: pharmacological treatment of hyperglycaemia; Introduction; Metformin (British National Formulary, Section 6.1.2.2); Sulphonylureas and meglitinides (prandial insulin regulators) (British National Formulary, Section 6.1.2.1); Thiazolidinediones (glitazones) (British National Formulary, Section 6.1.2.3); α-Glucosidase inhibitors (British National Formulary, Section 6.1.2.3)
Drugs acting on the incretin system (entero-insular axis)DPP-4 inhibitors (gliptins) (British National Formulary, Section 6.1.2.3); Pramlintide; Combination non-insulin treatment; Insulin treatment in type 2 diabetes; New developments; References; Further reading; 7 Infections in diabetes; Introduction; Types of infections; Chest infections; Infections after surgery; Urinary tract infections (British National Formulary, Section 5.1.13); Abdominal infections; Soft-tissue infections; Diabetic foot infections; Uncommon infections characteristic of diabetes; References; Further reading
8 Diabetic renal disease
|